Involvement of a non-human sialic Acid in human cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review of biochemical mechanisms and animal models with no original human clinical trial data
PubMed 24600589 · doi:10.3389/fonc.2014.00033
What was done
This review examined the biological mechanisms underlying the accumulation of the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) in human tissues and its link to cancer. The authors reviewed the evolutionary loss of functional CMAH in humans, dietary uptake of Neu5Gc (primarily from red meat), the generation of cross-reactive anti-Neu5Gc antibodies in humans, and experimental findings from human-like Neu5Gc-deficient Cmah(-/-) mouse models regarding antibody-mediated chronic inflammation ("xenosialitis").
What was found
The abstract reports no quantitative clinical data or exact numbers. It describes qualitatively that humans lack endogenous Neu5Gc production due to CMAH gene deletion but metabolically incorporate dietary Neu5Gc, which accumulates at elevated levels in certain human cancers. All humans develop circulating anti-Neu5Gc antibodies with diverse specificities. In Neu5Gc-deficient mouse models, the interaction between incorporated Neu5Gc and anti-Neu5Gc antibodies drives xenosialitis-mediated inflammation that promotes tumor progression.
Why it matters
This mechanistic framework provides a plausible biological explanation connecting dietary red meat consumption to elevated carcinoma risk and highlights potential avenues for cancer biomarkers and glycan-targeted immunotherapies.
Limits
The abstract details a narrative review rather than primary clinical trial or prospective epidemiological data. Tumor progression mechanisms are largely derived from Cmah-null mouse models and biochemical observations, which may not fully capture the complexity, variable antibody titers, or long-term dietary exposures found in diverse human populations.
Cited by
- contradicts Red meat contains the sialic acid Neu5Gc, which triggers an inflammatory response in all humans due to CMAH gene inactivation.